후두 현미경하 미세 수술에서 혈역학적 변화를 최소화하는 Propofol과 Remifentanil의 적정 용량 = Optimal dosages of propofol and remifentanil for minimizing hemodynamic changes during laryngeal microscopic surgery

다국어 초록 (Multilingual Abstract)

Background: Laryngeal microscopic surgery (LMS) is stressful to the patient due to intubation and suspension laryngoscopy. The aim of this study was to determine the optimal dosages of propofol and remifentanil for minimizing hemodynamic changes during LMS.
Methods: Eighty outpatients undergoing LMS were randomly divided into four groups. In all patients, endotracheal intubation was done with an effect-site concentration of propofol at 3 or 4μg/ml. Group I (propofol 3μg/ml) and II (propofol 4μg/ml) patients received remifentanil 0.5μg/kg and an infusion at 0.1μg/kg/min. Group III (propofol 3μg/ml) and IV (propofol 4μg/ml) patients received remifentanil 1.0μg/kg and an infusion at 0.2μg/kg/min. Hemodynamic changes and bispectral index (BIS) values during intubation and suspension laryngoscopy were compared among the groups. In addition, extubation time, emergence time, and state of recovery (Steward score) were compared.
Results: After intubation and suspension laryngoscopy, the mean arterial pressure (MAP) was significantly lower than baseline values in groups II and IV (P ＜ 0.05). After suspension laryngoscopy, the heart rate (HR) was significantly lower than baseline value in group II (P ＜ 0.05). Extubation time was significantly shorter in groups I, II, and III compared to group IV, and the time for responding to verbal commands was significantly shorter in groups I and II compared to group IV (P ＜ 0.05). The incidence of hypotension was higher in group IV than in the other groups (P ＜ 0.05).
Conclusions: The results suggest that an effect-site concentration of propofol at 4μg/ml with remifentanil 0.5μg/kg and infusion of 0.1μg/kg/min provide proper anesthesia with minimal hemodynamic changes during LMS.

다국어 초록 (Multilingual Abstract)

Background: Laryngeal microscopic surgery (LMS) is stressful to the patient due to intubation and suspension laryngoscopy. The aim of this study was to determine the optimal dosages of propofol and remifentanil for minimizing hemodynamic changes during LMS.
Methods: Eighty outpatients undergoing LMS were randomly divided into four groups. In all patients, endotracheal intubation was done with an effect-site concentration of propofol at 3 or 4μg/ml. Group I (propofol 3μg/ml) and II (propofol 4μg/ml) patients received remifentanil 0.5μg/kg and an infusion at 0.1μg/kg/min. Group III (propofol 3μg/ml) and IV (propofol 4μg/ml) patients received remifentanil 1.0μg/kg and an infusion at 0.2μg/kg/min. Hemodynamic changes and bispectral index (BIS) values during intubation and suspension laryngoscopy were compared among the groups. In addition, extubation time, emergence time, and state of recovery (Steward score) were compared.
Results: After intubation and suspension laryngoscopy, the mean arterial pressure (MAP) was significantly lower than baseline values in groups II and IV (P ＜ 0.05). After suspension laryngoscopy, the heart rate (HR) was significantly lower than baseline value in group II (P ＜ 0.05). Extubation time was significantly shorter in groups I, II, and III compared to group IV, and the time for responding to verbal commands was significantly shorter in groups I and II compared to group IV (P ＜ 0.05). The incidence of hypotension was higher in group IV than in the other groups (P ＜ 0.05).
Conclusions: The results suggest that an effect-site concentration of propofol at 4μg/ml with remifentanil 0.5μg/kg and infusion of 0.1μg/kg/min provide proper anesthesia with minimal hemodynamic changes during LMS.

참고문헌 (Reference)

• 1 김시오, "후두현미경하 미세수술을 위한 외래마취 시 Propofol과 Remifentanil을 이용한 전 정맥마취와 Sevoflurane-N2O와 Alfentanil을 이용한 균형마취의 비교" 대한마취과학회 53 (53): 350-355, 2007
• 2 박수현, "후두 현미경하 미세수술에서 완전정맥마취 시 remifentanil의 효과처 농도에 따른 혈역학적 변화" 대한마취과학회 52 (52): 9-15, 2007
• 3 김지연, "후두 현미경하 미세수술시 alfentanil투여가 혈역학적 반응과 회복양상에 미치는 영향" 대한마취과학회 50 (50): 396-401, 2006
• 4 Albertin A, "The effect-site concentration of remifentanil blunting cardiovascular responses to tracheal intubation and skin incision during bispectral index-guided propofol anesthesia" 101 : 125-130, 2005
• 5 Guignard B, "The effect of remifentanil on the bispectral index change and hemodynamic responses after orotracheal intubation" 90 : 161-167, 2000
• 6 Kil HY, "The bispectral index and modified observer's assessment of alertness/sedation scale comparable to effect site concentration of propofol in Koreans" 38 : 251-257, 2000
• 7 Beers R, "Remifentanil update: clinical science and utility" 18 : 1085-1104, 2004
• 8 유병훈, "Propofol 주입 시 기관 내 삽관에 따른 심혈관 반응을 억제하는 성별 Remifentanil 효과처 농도" 대한마취과학회 52 (52): 521-525, 2007
• 9 이홍식, "Propofol 마취에서 기관내 삽관 시 Remifentanil의 효과처 농도에 따른 혈역학과 Bispectral Index의 변화" 대한마취과학회 53 (53): 565-570, 2007
• 10 Vuyk J, "Pharmacodynamics of propofol in female patients" 77 : 3-9, 1992
• 11 Bouillon TW, "Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy" 100 : 1353-1372, 2004
• 12 Pandazi AK, "Inhalational anesthetic technique in microlaryngeal surgery: A comparison between sevoflurane-remifentanil and sevoflurane- alfentanil anesthesia" 112 : 373-378, 2003
• 13 Thompson JP, "Effect of remifentanil on the haemodynamic response to orotracheal intubation" 80 : 467-469, 1998
• 14 Hughes MA, "Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs" 76 : 334-341, 1992
• 15 Doze VA, "Comparison of propofol with methohexital for outpatient anesthesia" 65 : 1189-1195, 1986